Vitamin Shoppe, Inc. (VSI) At $4.25 Forms Bottom; Gain Capital Holdings (GCAP) Shorts Increased By 6.75%

Vitamin Shoppe, Inc. (VSI) formed multiple bottom with $3.87 target or 9.00% below today’s $4.25 share price. Vitamin Shoppe, Inc. (VSI) has $101.88M valuation. The stock decreased 4.49% or $0.2 during the last trading session, reaching $4.25. About 562,981 shares traded. Vitamin Shoppe, Inc. (NYSE:VSI) has declined 57.70% since February 17, 2017 and is downtrending. It has underperformed by 74.40% the S&P500.

Gain Capital Holdings Incorporated (NYSE:GCAP) had an increase of 6.75% in short interest. GCAP’s SI was 4.65 million shares in February as released by FINRA. Its up 6.75% from 4.35 million shares previously. With 617,600 avg volume, 8 days are for Gain Capital Holdings Incorporated (NYSE:GCAP)’s short sellers to cover GCAP’s short positions. The SI to Gain Capital Holdings Incorporated’s float is 19.31%. The stock decreased 2.11% or $0.15 during the last trading session, reaching $6.96. About 618,457 shares traded. GAIN Capital Holdings, Inc. (NYSE:GCAP) has declined 12.52% since February 17, 2017 and is downtrending. It has underperformed by 29.22% the S&P500.

Among 11 analysts covering Vitamin Shoppe (NYSE:VSI), 1 have Buy rating, 2 Sell and 8 Hold. Therefore 9% are positive. Vitamin Shoppe has $41 highest and $3 lowest target. $19.67’s average target is 362.82% above currents $4.25 stock price. Vitamin Shoppe had 26 analyst reports since August 6, 2015 according to SRatingsIntel. The company was upgraded on Saturday, August 8 by Zacks. Barclays Capital initiated the shares of VSI in report on Friday, September 23 with “Equal Weight” rating. Morgan Stanley maintained it with “Equal-Weight” rating and $8 target in Thursday, August 10 report. The stock of Vitamin Shoppe, Inc. (NYSE:VSI) earned “Equal-Weight” rating by Barclays Capital on Thursday, August 10. The stock has “Underweight” rating by Morgan Stanley on Tuesday, January 17. The firm earned “Neutral” rating on Thursday, October 27 by JP Morgan. The firm has “Neutral” rating given on Tuesday, November 17 by Robert W. Baird. Morgan Stanley maintained it with “Equal-Weight” rating and $4 target in Thursday, November 9 report. Barclays Capital maintained Vitamin Shoppe, Inc. (NYSE:VSI) rating on Thursday, November 9. Barclays Capital has “Equal-Weight” rating and $3 target. The stock of Vitamin Shoppe, Inc. (NYSE:VSI) has “Hold” rating given on Thursday, November 5 by Deutsche Bank.

Analysts await Vitamin Shoppe, Inc. (NYSE:VSI) to report earnings on March, 7. They expect $-0.24 EPS, down 166.67% or $0.60 from last year’s $0.36 per share. After $-0.03 actual EPS reported by Vitamin Shoppe, Inc. for the previous quarter, Wall Street now forecasts 700.00% negative EPS growth.

Among 6 analysts covering Gain Capital Holdings (NYSE:GCAP), 1 have Buy rating, 0 Sell and 5 Hold. Therefore 17% are positive. Gain Capital Holdings had 15 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of GAIN Capital Holdings, Inc. (NYSE:GCAP) has “Hold” rating given on Monday, January 8 by Sandler O’Neill. The stock of GAIN Capital Holdings, Inc. (NYSE:GCAP) earned “Buy” rating by Jefferies on Wednesday, March 8. Jefferies maintained GAIN Capital Holdings, Inc. (NYSE:GCAP) on Thursday, August 3 with “Buy” rating. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Thursday, August 17. The firm earned “Buy” rating on Tuesday, January 16 by Jefferies. The stock of GAIN Capital Holdings, Inc. (NYSE:GCAP) has “Buy” rating given on Monday, October 16 by Jefferies. The firm has “Hold” rating by Keefe Bruyette & Woods given on Friday, June 9. Keefe Bruyette & Woods maintained GAIN Capital Holdings, Inc. (NYSE:GCAP) rating on Friday, November 10. Keefe Bruyette & Woods has “Hold” rating and $7.0 target. Wood maintained it with “Hold” rating and $7.50 target in Tuesday, April 11 report. On Thursday, December 21 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”.

Since August 14, 2017, it had 0 insider buys, and 2 sales for $336,356 activity. $35,000 worth of GAIN Capital Holdings, Inc. (NYSE:GCAP) shares were sold by Calhoun Christopher Warren. Another trade for 36,000 shares valued at $301,356 was made by Roady Samantha on Tuesday, January 16.

Investors sentiment increased to 1.53 in 2017 Q3. Its up 0.53, from 1 in 2017Q2. It improved, as 7 investors sold GAIN Capital Holdings, Inc. shares while 23 reduced holdings. 18 funds opened positions while 28 raised stakes. 23.73 million shares or 0.04% less from 23.74 million shares in 2017Q2 were reported. Martingale Asset Management Lp holds 16,120 shares. Citigroup Inc reported 18,310 shares. Alpine Woods Investors Limited Liability holds 0.01% of its portfolio in GAIN Capital Holdings, Inc. (NYSE:GCAP) for 25,000 shares. Tudor Inv Et Al invested in 18,322 shares. 408,131 were accumulated by Matarin Capital Management Limited Liability Corporation. Principal Financial Gru Inc holds 0% or 19,077 shares in its portfolio. Millennium Mgmt Ltd accumulated 0% or 181,012 shares. Cove Street Capital Ltd Limited Liability Company holds 0.16% of its portfolio in GAIN Capital Holdings, Inc. (NYSE:GCAP) for 230,000 shares. Buckhead Cap Management Ltd Com owns 29,385 shares. Bridgeway Inc holds 380,205 shares. Axa has invested 0% in GAIN Capital Holdings, Inc. (NYSE:GCAP). Indexiq Advsrs Llc invested in 0.03% or 104,048 shares. Connor Clark And Lunn Investment Management Ltd holds 0% in GAIN Capital Holdings, Inc. (NYSE:GCAP) or 16,100 shares. Cornerstone Capital Management Lc accumulated 105,300 shares or 0.01% of the stock. Legal & General Group Incorporated Public Limited owns 8,411 shares.

GAIN Capital Holdings, Inc. provides trading services and solutions to retail, institutional, and futures service clients worldwide. The company has market cap of $313.74 million. The firm operates in three divisions: Retail, Institutional, and Futures. It has a 22.67 P/E ratio. It specializes in over-the-counter and exchange-traded markets.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: